The present study shows that SIL exerts cardioprotective effects by modulating the HIF-1α-glycolytic pathway, leading to the downregulation of key glycolytic enzymes (GLUT1, PFKFB3, LDHA) and the restoration of metabolic homeostasis in heart failure. Here, SLC2A1 is linked to heart failure.